Concepedia

Maria Gargano

MG

5

Publications

1.4K

Citations

5

H-Index

2013

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Dana-Farber Brigham Cancer Center

Massachusetts General Hospital

Maria Gargano is an author at Dana-Farber Cancer Institute specializing in tumor immunity, pathology, and vascular biology.

Top concepts

Publications per year

2013–2020

5

Publications

5

Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano et al. · Cancer Immunology Research · 2014 · 595 citations · Full text

, , +16

Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements

Mizuki Nishino, Anita Giobbie‐Hurder, Maria Gargano et al. · Clinical Cancer Research · 2013 · 507 citations · Full text

Characterization of Thyroid Disorders in Patients Receiving Immune Checkpoint Inhibition Therapy

Hyunju Lee, F. Stephen Hodi, Anita Giobbie‐Hurder et al. · Cancer Immunology Research · 2017 · 158 citations · Full text

Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?

Mizuki Nishino, Maria Gargano, Margaret Suda et al. · Journal for ImmunoTherapy of Cancer · 2014 · 94 citations · Full text

Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor‐induced colitis

Shilpa Grover, Michael Dougan, Kevin Tyan et al. · Cancer · 2020 · 65 citations · Full text

Rows per page

1–5 of 5